Biochemical and molecular pharmacological aspects of transporters as determinants of drug disposition
- PMID: 15855719
- DOI: 10.2133/dmpk.20.91
Biochemical and molecular pharmacological aspects of transporters as determinants of drug disposition
Abstract
Membrane transporters are integral membrane proteins typically having 12 transmembrane domains. Most of the SLC family transporters consist of 300-800 amino acid residues with a molecular mass of 40-90 kDa, while the corresponding values of ABC family transporters are 1,200-1,500 residues and 140-180 kDa, respectively. Each transporter has a characteristic tissue distribution and subcellular localization. I have isolated cDNAs of various transporters, including oligopeptide transporter PEPT1, monocarboxylic acid transporter MCT1 and organic cation/carnitine transporters (OCTNs), and determined their tissue distribution and subcellular localization. I have also determined the absolute expression levels of transporters to evaluate their relative contributions to drug transport in various tissues. It is important to note that expression levels of transporters can be changed under various physiological conditions and by administration of drugs. Changes in expression level, subcellular localization and functional properties can all be involved in inter-individual differences in drug pharmacokinetics. Transporters are among the key determinants of drug disposition.
Similar articles
-
Role of SLC xenobiotic transporters and their regulatory mechanisms PDZ proteins in drug delivery and disposition.J Control Release. 2006 Nov 28;116(2):238-46. doi: 10.1016/j.jconrel.2006.06.009. Epub 2006 Jun 15. J Control Release. 2006. PMID: 16876283 Review.
-
Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells.Eur J Pharm Sci. 2006 Nov;29(3-4):269-77. doi: 10.1016/j.ejps.2006.04.010. Epub 2006 May 2. Eur J Pharm Sci. 2006. PMID: 16822659
-
Mutation in an adaptor protein PDZK1 affects transport activity of organic cation transporter OCTNs and oligopeptide transporter PEPT2.Drug Metab Pharmacokinet. 2006 Oct;21(5):375-83. doi: 10.2133/dmpk.21.375. Drug Metab Pharmacokinet. 2006. PMID: 17072090
-
Regulation of drug transporters by PDZ adaptor proteins and nuclear receptors.Eur J Pharm Sci. 2006 Apr;27(5):487-500. doi: 10.1016/j.ejps.2005.11.006. Epub 2006 Jan 11. Eur J Pharm Sci. 2006. PMID: 16376527 Review.
-
Organic Cation Transporters in Human Physiology, Pharmacology, and Toxicology.Int J Mol Sci. 2020 Oct 24;21(21):7890. doi: 10.3390/ijms21217890. Int J Mol Sci. 2020. PMID: 33114309 Free PMC article. Review.
Cited by
-
Immunocytochemistry for bestatin and its application to drug accumulation studies in rat intestine and kidney.J Mol Histol. 2011 Dec;42(6):589-96. doi: 10.1007/s10735-011-9365-z. Epub 2011 Oct 18. J Mol Histol. 2011. PMID: 22006287
-
Mechanistic interpretation of conventional Michaelis-Menten parameters in a transporter system.Eur J Pharm Sci. 2014 Nov 20;64:44-52. doi: 10.1016/j.ejps.2014.08.007. Epub 2014 Aug 27. Eur J Pharm Sci. 2014. PMID: 25169756 Free PMC article.
-
Functional and Physiological Implications of Oligopeptide Transporters: Potential Targets for Pharmacological Interventions.J Membr Biol. 2025 May 29. doi: 10.1007/s00232-025-00348-1. Online ahead of print. J Membr Biol. 2025. PMID: 40442308 Review.
-
Adaptive response to increased bile acids: induction of MDR1 gene expression and P-glycoprotein activity in renal epithelial cells.Pflugers Arch. 2007 Jul;454(4):587-94. doi: 10.1007/s00424-007-0235-1. Epub 2007 Feb 27. Pflugers Arch. 2007. PMID: 17333245
-
Role of in vitro two-dimensional (2D) and three-dimensional (3D) cell culture systems for ADME-Tox screening in drug discovery and development: a comprehensive review.ADMET DMPK. 2022 Oct 10;11(1):1-32. doi: 10.5599/admet.1513. eCollection 2023. ADMET DMPK. 2022. PMID: 36778905 Free PMC article. Review.